Evidence map›Paper›PMID 36918431›Full record

ReviewChirurgie (Heidelberg, Germany)2023

[Pharmacotherapy of obesity-Competition to bariatric surgery or a meaningful supplement?]

Tina Mazaheri, Saleem Ansari, Madhavi Nallagonda, Lars Kollmann, Felix Nickel, Florian Seyfried, Alexander Dimitri Miras

Open access · greenAbstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Chirurgie (Heidelberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Tina MazaheriDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, Großbritannien.
Saleem AnsariDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, Großbritannien.
Madhavi NallagondaDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, Großbritannien.
Lars KollmannKlinik für Allgemein‑, Viszeral‑, Transplantation‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Würzburg, Deutschland.
Felix NickelKlinik für Allgemein-, Viszeral- und Thoraxchirurgie, Universitätsklinikum Hamburg Eppendorf, Hamburg, Deutschland.
Florian SeyfriedKlinik für Allgemein‑, Viszeral‑, Transplantation‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Würzburg, Deutschland. Seyfried_F@ukw.de.
Alexander Dimitri MirasDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, Großbritannien.
Imperial College London · GBUniversitätsklinikum Würzburg · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a complex chronic disease and requires a long-term multimodal approach. The current treatment algorithm for treatment of obesity mainly consists of a stepwise approach, which starts with a lifestyle intervention followed by or combined with medication treatment, whereas bariatric surgery is often reserved for the last option. This article provides an overview of the currently available conservative medicinal treatment regimens and the currently approved medications as well as medications currently undergoing approval studies with respect to the efficacy and possible side effects. Special attention is paid to the importance of combination treatment of pharmacotherapy and surgery in the sense of a multimodal treatment. The data so far show that using a multimodal approach an improvement in the long-term weight loss and metabolic benefits can be achieved for the patients.

Indexed as

Anti-Obesity AgentsBariatric SurgeryCombined Modality TherapyHumansLife StyleObesityAnti-Obesity AgentsCombined treatmentEfficacyLong-term weight lossSide effectsTreatment algorithm

Identifiers

PMID36918431
OpenAlexW4324136407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.